US 12209116
Recombinant human C1 esterase inhibitor and uses thereof
granted A61KA61K38/00A61K38/57
Quick answer
US patent 12209116 (Recombinant human C1 esterase inhibitor and uses thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/00, A61K38/57, A61K9/19, A61P